ArticleAnnals of translational medicine2021

Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas.

Zhiqiang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.